Edward Wirth - Net Worth and Insider Trading

Edward Wirth Net Worth

The estimated net worth of Edward Wirth is at least $0 dollars as of 2024-11-13. Edward Wirth is the Chief Medical Officer of Asterias Biotherapeutics Inc and owns about 0 shares of Asterias Biotherapeutics Inc (AST) stock worth over $0. Details can be seen in Edward Wirth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward Wirth has not made any transactions after 2017-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Edward Wirth

To

Edward Wirth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Wirth owns 3 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , Asterias Biotherapeutics Inc (AST) , and InVivo Therapeutics Holdings Corp (NVIVQ) .

Click here to see the complete history of Edward Wirth’s form 4 insider trades.

Insider Ownership Summary of Edward Wirth

Ticker Comapny Transaction Date Type of Owner
LCTX Lineage Cell Therapeutics Inc 2019-03-19 Chief Medical Officer
AST Asterias Biotherapeutics Inc 2019-03-01 Chief Medical Officer
NVIVQ InVivo Therapeutics Holdings Corp 2011-12-05 Chief Science Officer

Edward Wirth Latest Holdings Summary

Edward Wirth currently owns a total of 1 stock. Edward Wirth owns 0 shares of Asterias Biotherapeutics Inc (AST) as of January 9, 2017, with a value of $0.

Latest Holdings of Edward Wirth

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AST Asterias Biotherapeutics Inc 2017-01-09 0 0.95 0

Holding Weightings of Edward Wirth


Edward Wirth Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward Wirth has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the sale of 3,415 shares on January 9, 2017, which brought Edward Wirth around $15,709.

Insider Trading History of Edward Wirth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward Wirth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward Wirth Ownership Network

Ownership Network List of Edward Wirth

No Data

Ownership Network Relation of Edward Wirth

Insider Network Chart

Edward Wirth Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Who are the key executives at Lineage Cell Therapeutics Inc?

Edward Wirth is the Chief Medical Officer of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , director & President and CEO Brian M Culley , and 10 percent owner Broadwood Partners Lp .

Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary

Over the past 18 months, Edward Wirth made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,500 shares made by Jill Ann Howe .

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 10,500 shares, with a net purchase of 10,500 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,857,425 shares were bought by its insiders, resulting in a net purchase of 6,857,425 shares.

Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lineage Cell Therapeutics Inc Insider Transactions

No Available Data

Edward Wirth Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Wirth. You might contact Edward Wirth via mailing address: C/o Invivo Therapeutics Holding Corp., One Broadway, 14th Floor, Cambridge Ma 02142.